AMARIN Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AMARIN, and what generic alternatives to AMARIN drugs are available?
AMARIN has two approved drugs.
There are seventy US patents protecting AMARIN drugs.
There are three hundred and nine patent family members on AMARIN drugs in forty-five countries and twenty supplementary protection certificates in thirteen countries.
Summary for AMARIN
International Patents: | 309 |
US Patents: | 70 |
Tradenames: | 2 |
Ingredients: | 2 |
NDAs: | 2 |
Patent Litigation for AMARIN: | See patent lawsuits for AMARIN |
Drugs and US Patents for AMARIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Amarin Pharms | VASCEPA | icosapent ethyl | CAPSULE;ORAL | 202057-001 | Jul 26, 2012 | AB | RX | Yes | Yes | 8,551,521 | ⤷ Try a Trial | ⤷ Try a Trial | |||
Amarin Pharms | VASCEPA | icosapent ethyl | CAPSULE;ORAL | 202057-001 | Jul 26, 2012 | AB | RX | Yes | Yes | 8,669,245 | ⤷ Try a Trial | ⤷ Try a Trial | |||
Amarin Pharms | VASCEPA | icosapent ethyl | CAPSULE;ORAL | 202057-002 | Feb 16, 2017 | AB | RX | Yes | No | 9,700,537 | ⤷ Try a Trial | ⤷ Try a Trial | |||
Amarin Pharms | VASCEPA | icosapent ethyl | CAPSULE;ORAL | 202057-001 | Jul 26, 2012 | AB | RX | Yes | Yes | 9,700,537 | ⤷ Try a Trial | ⤷ Try a Trial | |||
Amarin Pharms | VASCEPA | icosapent ethyl | CAPSULE;ORAL | 202057-002 | Feb 16, 2017 | AB | RX | Yes | No | 9,693,986 | ⤷ Try a Trial | ⤷ Try a Trial | |||
Amarin Pharms | VASCEPA | icosapent ethyl | CAPSULE;ORAL | 202057-002 | Feb 16, 2017 | AB | RX | Yes | No | 8,357,677 | ⤷ Try a Trial | ⤷ Try a Trial | |||
Amarin Pharms | VASCEPA | icosapent ethyl | CAPSULE;ORAL | 202057-002 | Feb 16, 2017 | AB | RX | Yes | No | 10,278,937 | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for AMARIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Amarin Pharms | VASCEPA | icosapent ethyl | CAPSULE;ORAL | 202057-001 | Jul 26, 2012 | 8,188,146 | ⤷ Try a Trial |
Amarin Pharms | VASCEPA | icosapent ethyl | CAPSULE;ORAL | 202057-002 | Feb 16, 2017 | 8,188,146 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for AMARIN drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Capsules | 1 g | ➤ Subscribe | 2016-07-26 |
➤ Subscribe | Capsules | 1 g | ➤ Subscribe | 2013-01-15 |
➤ Subscribe | Capsules | 500 mg | ➤ Subscribe | 2017-08-29 |
International Patents for AMARIN Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Mexico | 2021002553 | ⤷ Try a Trial |
Portugal | 2424356 | ⤷ Try a Trial |
Hong Kong | 1256163 | ⤷ Try a Trial |
China | 114053258 | ⤷ Try a Trial |
Spain | 2647246 | ⤷ Try a Trial |
Canada | 3042062 | ⤷ Try a Trial |
New Zealand | 620473 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for AMARIN Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2443246 | CR 2021 00036 | Denmark | ⤷ Try a Trial | PRODUCT NAME: ICOSAPENT ETHYL; REG. NO/DATE: EU/1/20/1524 20210329 |
2443246 | C202130052 | Spain | ⤷ Try a Trial | PRODUCT NAME: ICOSAPENTO DE ETILO; NATIONAL AUTHORISATION NUMBER: EU/1/20/1524; DATE OF AUTHORISATION: 20210326; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/20/1524; DATE OF FIRST AUTHORISATION IN EEA: 20210326 |
2443246 | PA2021522 | Lithuania | ⤷ Try a Trial | PRODUCT NAME: IKOZAPENTO ETILAS; REGISTRATION NO/DATE: EU/1/20/1524 20210326 |
2443246 | LUC00226 | Luxembourg | ⤷ Try a Trial | PRODUCT NAME: ICOSAPENT ETHYL; AUTHORISATION NUMBER AND DATE: EU/1/20/1524 20210329 |
2443246 | 132021000000156 | Italy | ⤷ Try a Trial | PRODUCT NAME: ICOSAPENT ETILE(VAZKEPA); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/20/1524, 20210329 |
2443246 | 2021C/538 | Belgium | ⤷ Try a Trial | PRODUCT NAME: VAZKEPA - ICOSAPENT ETHYL; AUTHORISATION NUMBER AND DATE: EU/1/20/1524 20210329 |
2443246 | 21C1046 | France | ⤷ Try a Trial | PRODUCT NAME: ICOSAPENT ETHYL; NAT. REGISTRATION NO/DATE: EU/1/20/1524 20210329; FIRST REGISTRATION: - EU/1/20/1524 20210329 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.